These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16952007)

  • 1. Non-competitive inhibitory activities of morphinan and morphine derivatives at the alpha 3 beta 4 Neuronal nicotinic acetylcholine receptor determined using nonlinear chromatography and chemometric techniques.
    Jozwiak K; Moaddel R; Yamaguchi R; Maciuk A; Wainer IW
    Pharm Res; 2006 Sep; 23(9):2175-82. PubMed ID: 16952007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational mobility of immobilized alpha3beta2, alpha3beta4, alpha4beta2, and alpha4beta4 nicotinic acetylcholine receptors.
    Moaddel R; Jozwiak K; Whittington K; Wainer IW
    Anal Chem; 2005 Feb; 77(3):895-901. PubMed ID: 15679359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
    Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
    J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine alpha 4 beta 2 receptor.
    Gopalakrishnan M; Monteggia LM; Anderson DJ; Molinari EJ; Piattoni-Kaplan M; Donnelly-Roberts D; Arneric SP; Sullivan JP
    J Pharmacol Exp Ther; 1996 Jan; 276(1):289-97. PubMed ID: 8558445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of rat alpha3beta4 nicotinic receptor function by methadone, its metabolites, and structural analogs.
    Xiao Y; Smith RD; Caruso FS; Kellar KJ
    J Pharmacol Exp Ther; 2001 Oct; 299(1):366-71. PubMed ID: 11561100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between the increased cell surface alpha7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists.
    Jonnala RR; Buccafusco JJ
    J Neurosci Res; 2001 Nov; 66(4):565-72. PubMed ID: 11746376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On-line screening of conformationally constrained nicotines and anabasines for agonist activity at the alpha3beta4- and alpha4beta2-nicotinic acetylcholine receptors using immobilized receptor-based liquid chromatographic stationary phases.
    Moaddel R; Jozwiak K; Yamaguchi R; Cobello C; Whittington K; Sarkar TK; Basak S; Wainer IW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 813(1-2):235-40. PubMed ID: 15556538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine activates cell-signaling pathways through muscle-type and neuronal nicotinic acetylcholine receptors in non-small cell lung cancer cells.
    Carlisle DL; Liu X; Hopkins TM; Swick MC; Dhir R; Siegfried JM
    Pulm Pharmacol Ther; 2007; 20(6):629-41. PubMed ID: 17015027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of nicotinic acetylcholine receptor beta subunits in function of human alpha4-containing nicotinic receptors.
    Wu J; Liu Q; Yu K; Hu J; Kuo YP; Segerberg M; St John PA; Lukas RJ
    J Physiol; 2006 Oct; 576(Pt 1):103-18. PubMed ID: 16825297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of prolonged nicotinic ligand exposure on function of heterologously expressed, human alpha4beta2- and alpha4beta4-nicotinic acetylcholine receptors.
    Gentry CL; Wilkins LH; Lukas RJ
    J Pharmacol Exp Ther; 2003 Jan; 304(1):206-16. PubMed ID: 12490593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The comparative pharmacology and up-regulation of rat neuronal nicotinic receptor subtype binding sites stably expressed in transfected mammalian cells.
    Xiao Y; Kellar KJ
    J Pharmacol Exp Ther; 2004 Jul; 310(1):98-107. PubMed ID: 15016836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotine-morphine interactions at α4β2, α7 and α3(⁎) nicotinic acetylcholine receptors.
    Talka R; Salminen O; Whiteaker P; Lukas RJ; Tuominen RK
    Eur J Pharmacol; 2013 Feb; 701(1-3):57-64. PubMed ID: 23340223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of noncompetitive inhibitors with an immobilized alpha3beta4 nicotinic acetylcholine receptor investigated by affinity chromatography, quantitative-structure activity relationship analysis, and molecular docking.
    Jozwiak K; Ravichandran S; Collins JR; Wainer IW
    J Med Chem; 2004 Jul; 47(16):4008-21. PubMed ID: 15267239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chronic nicotine treatment on expression of diverse nicotinic acetylcholine receptor subtypes. I. Dose- and time-dependent effects of nicotine treatment.
    Ke L; Eisenhour CM; Bencherif M; Lukas RJ
    J Pharmacol Exp Ther; 1998 Aug; 286(2):825-40. PubMed ID: 9694939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional properties of homomeric, human alpha 7-nicotinic acetylcholine receptors heterologously expressed in the SH-EP1 human epithelial cell line.
    Zhao L; Kuo YP; George AA; Peng JH; Purandare MS; Schroeder KM; Lukas RJ; Wu J
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1132-41. PubMed ID: 12626641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective down-regulation of [(125)I]Y0-alpha-conotoxin MII binding in rat mesostriatal dopamine pathway following continuous infusion of nicotine.
    Mugnaini M; Garzotti M; Sartori I; Pilla M; Repeto P; Heidbreder CA; Tessari M
    Neuroscience; 2006; 137(2):565-72. PubMed ID: 16289885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal nicotinic receptor beta2 and beta4 subunits confer large differences in agonist binding affinity.
    Parker MJ; Beck A; Luetje CW
    Mol Pharmacol; 1998 Dec; 54(6):1132-9. PubMed ID: 9855644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered α4β2 nicotinic acetylcholine receptors as models for measuring agonist binding and effect at the orthosteric low-affinity α4-α4 interface.
    Ahring PK; Olsen JA; Nielsen EØ; Peters D; Pedersen MH; Rohde LA; Kastrup JS; Shahsavar A; Indurthi DC; Chebib M; Gajhede M; Balle T
    Neuropharmacology; 2015 May; 92():135-45. PubMed ID: 25595102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temperature and ionic strength dependence of quinacrine binding and quinacrine displacement elicited by high concentrations of agonists on the nicotinic acetylcholine receptor.
    Arias HR
    Arch Biochem Biophys; 1996 Sep; 333(1):1-11. PubMed ID: 8806747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Doxylstearate-induced displacement of phencyclidine from its low-affinity binding sites on the nicotinic acetylcholine receptor.
    Arias HR
    Arch Biochem Biophys; 1999 Nov; 371(1):89-97. PubMed ID: 10525293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.